BRIVOLIGIDE SODIUM
UNII 574AR4D1KJ

Substance Identification & Data

This profile provides standardized clinical and technical data for Brivoligide Sodium, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 574AR4D1KJ.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1803075-43-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
574AR4D1KJ
CAS Registry Number
1803075-43-5
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
BRIVOLIGIDE SODIUM
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
USAN ID
EF-143
Identifier assigned by the United States Adopted Names Council.
Substance Type
nucleicAcid
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Brivoligide Sodium. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

BRIVOLIGIDE SODIUM

Common Names & Synonyms

BRIVOLIGIDE SODIUM [USAN]

Systematic Nomenclature

DNA, D(C-T-A-C-G-C-C-C-A-C-C-G-C-C-C-A-C-G-C-A-T-A-C), COMPLEX WITH DNA D(G-T-A-T-G-C-G-T-G-G-G-C-G-G-T-G-G-G-C-G-T-A-G), SODIUM SALT (1:1:44)

Technical Codes

AYX1 SODIUM
AYX-1 SODIUM